Lantern Pharma Inc. has received a Certificate of Patent from the Japan Patent Office for their drug candidate LP-284, which uses their proprietary RADR®…
Lantern Pharma Inc. has received a Certificate of Patent from the Japan Patent Office for their drug candidate LP-284, which uses their proprietary RADR®…
Login below or Register Now.
Already registered? Login.